[Elsevier] Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility |
|
This post will be closed automatically in 2026-08-28 23:52
Reward10points
|
post
reply
points
10
10
Granulocyte chemotactic protein-2
10
Structural modification of ketorolac to improve cyclooxygenase-2 inhibition: A quantum chemical and computer-aided drug design approach
10
Evaluation of the clinical performance of different occlusal device materials
10
Refrigerants: There is still no vision for sustainable solutions
10
Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility
